Potent Antitumor Efficacy of Anti-GD2 CAR T Cells in H3-K27M+ Diffuse Midline Gliomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Potent Antitumor Efficacy of Anti-GD2 CAR T Cells in H3-K27M+ Diffuse Midline Gliomas
Nat. Med. 2018 Apr 16;[EPub Ahead of Print], CW Mount, RG Majzner, S Sundaresh, EP Arnold, M Kadapakkam, S Haile, L Labanieh, E Hulleman, PJ Woo, SP Rietberg, H Vogel, M Monje, CL MackallFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.